Biotech Values

[DewDiligence]

...the one-week-early FTC clearance for the PFE-MTSR merger (#msg-176890987) was not happenstance!

The politics underpinning this deal are in plain sight. E.g., this FoxBusiness article is unabashedly pro-PFE:

https://www.foxbusiness.com/fox-news-opinion/mike-davis-foreign-weight-loss-drugmaker-seeks-fat-profits-gobbling-up-american-upstart

Novo’s shady strategy is to make an early payment for Metsera shares. That would effectively give Novo economic control of Metsera and undue influence on the company before the transaction even undergoes regulatory review. While a Danish company buying an American one doesn’t necessarily represent an obvious threat to national security, permitting Novo to acquire a promising U.S.-based biotech company could lead to American job losses and profits getting sent abroad.

DJT Jr retweeted the FoxBusiness article: https://x.com/mroliverbarnes/status/1984997841312354626/photo/1 .